News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

SR Pharma PLC (SPA.L) Gets Encouraging Results In Mice For Pancreatic Cancer Drug



9/14/2006 2:44:19 PM

LONDON (AFX) - SR Pharma plc said it and its operating subsidiary Atugen AG have received encouraging results in mice under studies on the therapeutic efficacy of Atu027 RNAi treating pancreatic cancer.



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES